Consensus R1 RCM Inc. Nasdaq

Equities

RCM

US7493971052

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
11.9 USD +0.68% Intraday chart for R1 RCM Inc. -0.75% -49.62%

Evolution of the average Target Price on R1 RCM Inc.

Price target over the last 5 years

History of analyst recommendation changes

072a0f8c4dad8da3fc20702b80d9.uyxNQ4C6bzFquxn-aPwfASHk1sZ68b5fwtfWkhPHVOA.3FsicdLDOGRdjWOKAs1rQkWjhKg4h_o6q5_m8HrxMo_sWCwX8vQkYSTyUA~02fe33bb8dc0ff5d1f1683ab25c9913a
KeyBanc Downgrades R1 RCM to Sector Weight From Overweight on Potential Risks to Hospital End Markets MT
Canaccord Genuity Trims Price Target on R1 RCM to $16 From $17, Maintains Buy Rating MT
Citigroup Upgrades R1 RCM to Buy From Neutral, Price Target is $16 MT
Truist Securities Downgrades R1 RCM to Hold From Buy, Price Target is $16 MT
KeyBanc Raises Price Target on R1 RCM to $17 From $13, Maintains Overweight Rating MT
Barclays Downgrades R1 RCM to Equalweight From Overweight, Price Target is $14 MT
Evercore ISI Downgrades R1 RCM to In Line From Outperform, Raises Price Target to $16 From $12 MT
Deutsche Bank Downgrades R1 RCM to Hold From Buy, $15 Price Target MT
Deutsche Bank Trims R1 RCM Price Target to $15 From $16, Maintains Buy Rating MT
Leerink Partners Initiates R1 RCM at Outperform Rating With $14 Price Target MT
TD Cowen Cuts R1 RCM Price Target to $20 From $26, Maintains Outperform Rating MT
Morgan Stanley Upgrades R1 RCM to Overweight From Equalweight, Trims Price Target to $17 From $17.50 MT
JPMorgan Downgrades R1 RCM to Neutral From Overweight, Cuts Price Target to $11 From $20 MT
Deutsche Bank Adjusts R1 RCM Price Target to $16 From $19, Maintains Buy Rating MT
Deutsche Bank Cuts R1 RCM Price Target to $19 From $22, Maintains Buy Rating MT
KeyBanc Adjusts R1 RCM Price Target to $18 From $20, Maintains Overweight Rating MT
RBC Cuts Price Target on R1 RCM to $19 From $22, Keeps Outperform Rating MT
Truist Securities Upgrades R1 RCM to Buy From Hold, Price Target is $18 MT
Cantor Fitzgerald Initiates R1 RCM at Overweight MT
Deutsche Bank Adjusts R1 RCM Price Target to $22 From $18, Maintains Buy Rating MT
Morgan Stanley Adjusts Price Target on R1 RCM to $19 From $16, Maintains Equalweight Rating MT
Barclays Adjusts Price Target on R1 RCM to $20 From $18, Maintains Overweight Rating MT
Jefferies Adjusts R1 RCM's Price Target to $22 From $20, Maintains Buy Rating MT
BofA Securities Adjusts R1 RCM's Price Target to $22 From $19, Keeps Buy Rating MT
Deutsche Bank Adjusts R1 RCM Price Target to $18 From $16, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
11.9 USD
Average target price
16.93 USD
Spread / Average Target
+42.26%
High Price Target
20 USD
Spread / Highest target
+68.07%
Low Price Target
14 USD
Spread / Lowest Target
+17.65%

Consensus detail

Consensus revision (last 18 months)

Analysts covering R1 RCM Inc.

KeyBanc Capital Markets
Canaccord Genuity
Citigroup
Truist Securities
Barclays
Evercore ISI
Deutsche Bank Securities
Leerink Partners
TD Cowen
Morgan Stanley
JPMorgan Chase
RBC Capital Markets
Cantor Fitzgerald
Jefferies & Co.
BofA Securities
Stephens Inc.
Baird
Guggenheim
Cowen
SVB Securities LLC
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings